Professor David W. Denning an extraordinary high achiever in clinical and translational science
IBJ-Iranian Biomedical Journal. 2018; 22 (5): 290-291
in En
| IMEMR
| ID: emr-199452
Responsible library:
EMRO
ABSTRACT
It is often wondered as to what part of all the research performed around the globe actually leaves the lab and reaches the real people and betters their lives. In case of Professor David W. Denning's research, a large part does. As a prominent international face in the field of medical mycology, he translates his research into clinical applications and takes medical problems back to his lab, in order to develop potential solutions. e is a professor of Infectious Diseases in Global Health and a consultant in infectious diseases and medical mycology, Wythenshawe Hospital and University of Manchester. He is also the founding president of the Global Action Fund for Fungal Infections [GAFFI] and the leader of Leading International Fungal Education [LIFE]. He supervises a strong research group funded by grants from the UK, USA, and Europe, as well as multiple pharmaceutical companies, with research grant income of more than 22 million pounds to Manchester University, since 1990
Search on Google
Index:
IMEMR
Language:
En
Journal:
Iran. Biomed. J.
Year:
2018